The development of induced pluripotent stem (IPS) cell-derived organoids is transforming research methodologies in regenerative medicine, drug testing, and disease modeling. The China IPS Cell Derived Organoids Market is experiencing remarkable growth, supported by government initiatives, increasing biotech funding, and expanding collaboration between research institutions and industry....
Bangla